NDRAENDRA Life Sciences Inc.
5.630USD+2.55%Mkt Cap: 7.00M USDP/E: Last update: 2026-06-01

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed …

Indicators:|

Key Statistics

Company
Market Cap7.00M USD
Enterprise Value7.09M USD
Revenue (TTM)
Gross Profit
Net Income (TTM)-7.03M USD
Revenue/Share
Last Price5.630 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees9
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.38
PEG
EV/EBITDA-1.10
EV/Revenue
P/S
P/B3.62
EPS (TTM)-8.16
EPS (Forward)-4.00
52W Range
2.96030% of range11.96
52W High11.96 USD
52W Low2.960 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-310.93%
ROA-182.35%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-5.18M USD
CapEx (TTM)3.02M USD
FCF Margin
FCF Yield-84.50%
Net Debt104.74K USD
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.22
Current Ratio0.64
Quick Ratio0.43
Book Value/Sh1.519 USD
Cash/Share0.2810 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:35
Split DateNov 7, 2024
Analyst Consensus
Rating
Target (Mean)27.00 USD
Target Range27.00 USD27.00 USD
# Analysts1
Ownership
Shares Out.1.27M
Float1.20M
Insiders14.21%
Institutions16.19%
Short Interest
Short Ratio1.7d
Short % Float2.72%
Short % Out.2.57%
Shares Short32.60K
Short (prev mo.)48.28K
Technical
SMA 504.934 (+14.1%)
SMA 2004.872 (+15.6%)
Beta
S&P 52W Chg27.94%
Avg Vol (30d)16.70K
Avg Vol (10d)21.49K
Technical Indicators
RSI (14)55.0
MACD0.1393
MACD Signal0.1536
MACD Hist.-0.0143
BB Upper5.913 USD
BB Middle5.285 USD
BB Lower4.656 USD
BB Width23.79%
ATR (14)0.4566 USD
Vol Ratio (20d)0.48x